Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Suárez-Gea ML"'
Publikováno v:
Vascular Health and Risk Management, Vol 2014, Iss default, Pp 627-639 (2014)
Antonio Gómez-Outes,1 Mª Luisa Suárez-Gea,1 Ramón Lecumberri,2 Ana Isabel Terleira-Fernández,3,4 Emilio Vargas-Castrillón3,41Division of Pharmacology and Clinical Evaluation, Medicines for Human Use, Spanish Agency for Medicines and Medical Dev
Externí odkaz:
https://doaj.org/article/fc98677aa4634ba38f8f9778de7d881f
Autor:
Gómez-Outes A, Suárez-Gea ML, Lecumberri R, Terleira-Fernández AI, Vargas-Castrillón E, Rocha E
Publikováno v:
Vascular Health and Risk Management, Vol 2013, Iss default, Pp 207-228 (2013)
Antonio Gómez-Outes,1 M Luisa Suárez-Gea,1 Ramón Lecumberri,2 Ana Isabel Terleira-Fernández,3,4 Emilio Vargas-Castrillón,3,4 Eduardo Rocha51Division of Pharmacology and Clinical Evaluation, Medicines for Human Use, Spanish Agency for Medicines a
Externí odkaz:
https://doaj.org/article/14384e814f624986b3475f2299cfff93
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
New England Journal of Medicine. 11/19/2009, Vol. 361 Issue 21, p2100-2101. 2p.
Autor:
Gómez-Outes A; Division of Pharmacology and Clinical Drug Evaluation, Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), Campezo 1, 28022, Madrid, Spain. agomezo@aemps.es., Suárez-Gea ML; Division of Pharmacology and Clinical Drug Evaluation, Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), Campezo 1, 28022, Madrid, Spain., Lecumberri R; Hematology Service, University Clinic of Navarra, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain.
Publikováno v:
Current cardiology reports [Curr Cardiol Rep] 2023 May; Vol. 25 (5), pp. 371-380. Date of Electronic Publication: 2023 Mar 28.
Autor:
Gómez-Outes A; Division of Pharmacology and Clinical Drug Evaluation, Medicines for Human Use, Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain., Suárez-Gea ML; Division of Pharmacology and Clinical Drug Evaluation, Medicines for Human Use, Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain., Pérez-Cabeza AI; Servicio de Cardiologia, Hospital Universitario Virgen de la Victoria, Instituto de Biomedicina de Málaga (IBIMA), Málaga, Spain.; Centro de Investigación Biomédica en Red-Cardiovascular (CIBER-CV), Instituto de Salud Carlos III, Madrid, Spain., García-Pinilla JM; Servicio de Cardiologia, Hospital Universitario Virgen de la Victoria, Instituto de Biomedicina de Málaga (IBIMA), Málaga, Spain.; Centro de Investigación Biomédica en Red-Cardiovascular (CIBER-CV), Instituto de Salud Carlos III, Madrid, Spain.
Publikováno v:
Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2022 Dec; Vol. 23 (17), pp. 1941-1955. Date of Electronic Publication: 2022 Nov 27.
Autor:
Gómez-Outes A; Division of Pharmacology and Clinical Drug Evaluation, Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain. Electronic address: agomezo@aemps.es., Alcubilla P; Department of Clinical Pharmacology, Hospital Clinic, Barcelona, Spain., Calvo-Rojas G; Department of Clinical Pharmacology, Hospital Clinic, Barcelona, Spain; University of Barcelona, Barcelona, Spain., Terleira-Fernández AI; Department of Clinical Pharmacology, Hospital Clínico San Carlos, IdISSC, Madrid, Spain; Department of Pharmacology, Universidad Complutense, IdISSC, Madrid, Spain., Suárez-Gea ML; Division of Pharmacology and Clinical Drug Evaluation, Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain., Lecumberri R; Hematology Service, University Clinic of Navarra, Pamplona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain., Vargas-Castrillón E; Department of Clinical Pharmacology, Hospital Clínico San Carlos, IdISSC, Madrid, Spain; Department of Pharmacology, Universidad Complutense, IdISSC, Madrid, Spain.
Publikováno v:
Journal of the American College of Cardiology [J Am Coll Cardiol] 2021 Jun 22; Vol. 77 (24), pp. 2987-3001.
Autor:
Gómez-Outes A; a Division of Pharmacology and Clinical Drug Evaluation, Medicines for Human Use , Spanish Agency for Medicines and Medical Devices (AEMPS) , Madrid , Spain., Suárez-Gea ML; a Division of Pharmacology and Clinical Drug Evaluation, Medicines for Human Use , Spanish Agency for Medicines and Medical Devices (AEMPS) , Madrid , Spain., García-Pinilla JM; b UGC de Cardiología y Cirugía Cardiovascular , Instituto de Biomedicina de Málaga (IBIMA), Hospital Universitario Virgen de la Victoria , Málaga , Spain.; c Centro de Investigación Biomédica en Red-Cardiovascular (CIBER-CV) , Instituto de Salud Carlos III , Madrid , Spain.
Publikováno v:
Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2018 Sep; Vol. 19 (13), pp. 1427-1440. Date of Electronic Publication: 2018 Sep 08.
Autor:
Gómez-Outes A; Division of Pharmacology and Clinical Drug Evaluation, Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain., Terleira-Fernández AI; Department of Clinical Pharmacology, Hospital Clínico San Carlos, Madrid, Spain.; Department of Pharmacology, Universidad Complutense, Madrid, Spain., Lecumberri R; Hematology Service, University Clinic of Navarra, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain., Suárez-Gea ML; Division of Pharmacology and Clinical Drug Evaluation, Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain., Calvo-Rojas G; Department of Clinical Pharmacology, Hospital Clinic, Barcelona, Spain., Vargas-Castrillón E; Department of Clinical Pharmacology, Hospital Clínico San Carlos, Madrid, Spain.; Department of Pharmacology, Universidad Complutense, Madrid, Spain.
Publikováno v:
Seminars in thrombosis and hemostasis [Semin Thromb Hemost] 2018 Jun; Vol. 44 (4), pp. 377-387. Date of Electronic Publication: 2018 May 03.
Autor:
Gómez-Outes A; a Division of Pharmacology and Clinical Drug Evaluation, Medicines for Human Use , Spanish Agency for Medicines and Medical Devices (AEMPS) , Madrid , Spain., García-Fuentes M; a Division of Pharmacology and Clinical Drug Evaluation, Medicines for Human Use , Spanish Agency for Medicines and Medical Devices (AEMPS) , Madrid , Spain., Suárez-Gea ML; a Division of Pharmacology and Clinical Drug Evaluation, Medicines for Human Use , Spanish Agency for Medicines and Medical Devices (AEMPS) , Madrid , Spain.
Publikováno v:
Expert opinion on drug discovery [Expert Opin Drug Discov] 2017 Dec; Vol. 12 (12), pp. 1195-1205. Date of Electronic Publication: 2017 Sep 27.